Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $784 - $1,256
400 New
400 $1,000
Q3 2019

Mar 16, 2021

SELL
$2.17 - $3.14 $21,917 - $31,714
-10,100 Closed
0 $0
Q2 2019

Mar 16, 2021

BUY
$2.53 - $3.04 $25,552 - $30,704
10,100 New
10,100 $30,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Axiom Investment Management LLC Portfolio

Follow Axiom Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investment Management LLC with notifications on news.